Breast Lesion Localization Decvice Market In Global
This report studies the Breast Lesion Localization Methods market, including wire localization ... Read More
1 Introduction to Research & Analysis Reports 1.1 Oncology Immuno Drug Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Oncology Immuno Drug Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Oncology Immuno Drug Overall Market Size 2.1 Global Oncology Immuno Drug Market Size: 2021 VS 2028 2.2 Global Oncology Immuno Drug Revenue, Prospects & Forecasts: 2017-2028 2.3 Global Oncology Immuno Drug Sales: 2017-2028 3 Company Landscape 3.1 Top Oncology Immuno Drug Players in Global Market 3.2 Top Global Oncology Immuno Drug Companies Ranked by Revenue 3.3 Global Oncology Immuno Drug Revenue by Companies 3.4 Global Oncology Immuno Drug Sales by Companies 3.5 Global Oncology Immuno Drug Price by Manufacturer (2017-2022) 3.6 Top 3 and Top 5 Oncology Immuno Drug Companies in Global Market, by Revenue in 2021 3.7 Global Manufacturers Oncology Immuno Drug Product Type 3.8 Tier 1, Tier 2 and Tier 3 Oncology Immuno Drug Players in Global Market 3.8.1 List of Global Tier 1 Oncology Immuno Drug Companies 3.8.2 List of Global Tier 2 and Tier 3 Oncology Immuno Drug Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Oncology Immuno Drug Market Size Markets, 2021 & 2028 4.1.2 Immune Checkpoint Inhibitors 4.1.3 Cytokine-Based Immunotherapy 4.1.4 Cancer Vaccines 4.1.5 CAR-T Cell Therapy 4.1.6 Other 4.2 By Type - Global Oncology Immuno Drug Revenue & Forecasts 4.2.1 By Type - Global Oncology Immuno Drug Revenue, 2017-2022 4.2.2 By Type - Global Oncology Immuno Drug Revenue, 2023-2028 4.2.3 By Type - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 4.3 By Type - Global Oncology Immuno Drug Sales & Forecasts 4.3.1 By Type - Global Oncology Immuno Drug Sales, 2017-2022 4.3.2 By Type - Global Oncology Immuno Drug Sales, 2023-2028 4.3.3 By Type - Global Oncology Immuno Drug Sales Market Share, 2017-2028 4.4 By Type - Global Oncology Immuno Drug Price (Manufacturers Selling Prices), 2017-2028 5 Sights By Application 5.1 Overview 5.1.1 By Application - Global Oncology Immuno Drug Market Size, 2021 & 2028 5.1.2 Hospitals 5.1.3 Drugstores 5.1.4 Others 5.2 By Application - Global Oncology Immuno Drug Revenue & Forecasts 5.2.1 By Application - Global Oncology Immuno Drug Revenue, 2017-2022 5.2.2 By Application - Global Oncology Immuno Drug Revenue, 2023-2028 5.2.3 By Application - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 5.3 By Application - Global Oncology Immuno Drug Sales & Forecasts 5.3.1 By Application - Global Oncology Immuno Drug Sales, 2017-2022 5.3.2 By Application - Global Oncology Immuno Drug Sales, 2023-2028 5.3.3 By Application - Global Oncology Immuno Drug Sales Market Share, 2017-2028 5.4 By Application - Global Oncology Immuno Drug Price (Manufacturers Selling Prices), 2017-2028 6 Sights by Region 6.1 By Region - Global Oncology Immuno Drug Market Size, 2021 & 2028 6.2 By Region - Global Oncology Immuno Drug Revenue & Forecasts 6.2.1 By Region - Global Oncology Immuno Drug Revenue, 2017-2022 6.2.2 By Region - Global Oncology Immuno Drug Revenue, 2023-2028 6.2.3 By Region - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 6.3 By Region - Global Oncology Immuno Drug Sales & Forecasts 6.3.1 By Region - Global Oncology Immuno Drug Sales, 2017-2022 6.3.2 By Region - Global Oncology Immuno Drug Sales, 2023-2028 6.3.3 By Region - Global Oncology Immuno Drug Sales Market Share, 2017-2028 6.4 North America 6.4.1 By Country - North America Oncology Immuno Drug Revenue, 2017-2028 6.4.2 By Country - North America Oncology Immuno Drug Sales, 2017-2028 6.4.3 US Oncology Immuno Drug Market Size, 2017-2028 6.4.4 Canada Oncology Immuno Drug Market Size, 2017-2028 6.4.5 Mexico Oncology Immuno Drug Market Size, 2017-2028 6.5 Europe 6.5.1 By Country - Europe Oncology Immuno Drug Revenue, 2017-2028 6.5.2 By Country - Europe Oncology Immuno Drug Sales, 2017-2028 6.5.3 Germany Oncology Immuno Drug Market Size, 2017-2028 6.5.4 France Oncology Immuno Drug Market Size, 2017-2028 6.5.5 U.K. Oncology Immuno Drug Market Size, 2017-2028 6.5.6 Italy Oncology Immuno Drug Market Size, 2017-2028 6.5.7 Russia Oncology Immuno Drug Market Size, 2017-2028 6.5.8 Nordic Countries Oncology Immuno Drug Market Size, 2017-2028 6.5.9 Benelux Oncology Immuno Drug Market Size, 2017-2028 6.6 Asia 6.6.1 By Region - Asia Oncology Immuno Drug Revenue, 2017-2028 6.6.2 By Region - Asia Oncology Immuno Drug Sales, 2017-2028 6.6.3 China Oncology Immuno Drug Market Size, 2017-2028 6.6.4 Japan Oncology Immuno Drug Market Size, 2017-2028 6.6.5 South Korea Oncology Immuno Drug Market Size, 2017-2028 6.6.6 Southeast Asia Oncology Immuno Drug Market Size, 2017-2028 6.6.7 India Oncology Immuno Drug Market Size, 2017-2028 6.7 South America 6.7.1 By Country - South America Oncology Immuno Drug Revenue, 2017-2028 6.7.2 By Country - South America Oncology Immuno Drug Sales, 2017-2028 6.7.3 Brazil Oncology Immuno Drug Market Size, 2017-2028 6.7.4 Argentina Oncology Immuno Drug Market Size, 2017-2028 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Oncology Immuno Drug Revenue, 2017-2028 6.8.2 By Country - Middle East & Africa Oncology Immuno Drug Sales, 2017-2028 6.8.3 Turkey Oncology Immuno Drug Market Size, 2017-2028 6.8.4 Israel Oncology Immuno Drug Market Size, 2017-2028 6.8.5 Saudi Arabia Oncology Immuno Drug Market Size, 2017-2028 6.8.6 UAE Oncology Immuno Drug Market Size, 2017-2028 7 Manufacturers & Brands Profiles 7.1 Bristol-Myers Squibb 7.1.1 Bristol-Myers Squibb Corporate Summary 7.1.2 Bristol-Myers Squibb Business Overview 7.1.3 Bristol-Myers Squibb Oncology Immuno Drug Major Product Offerings 7.1.4 Bristol-Myers Squibb Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.1.5 Bristol-Myers Squibb Key News 7.2 Merck & Co 7.2.1 Merck & Co Corporate Summary 7.2.2 Merck & Co Business Overview 7.2.3 Merck & Co Oncology Immuno Drug Major Product Offerings 7.2.4 Merck & Co Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.2.5 Merck & Co Key News 7.3 Roche AG 7.3.1 Roche AG Corporate Summary 7.3.2 Roche AG Business Overview 7.3.3 Roche AG Oncology Immuno Drug Major Product Offerings 7.3.4 Roche AG Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.3.5 Roche AG Key News 7.4 AstraZeneca 7.4.1 AstraZeneca Corporate Summary 7.4.2 AstraZeneca Business Overview 7.4.3 AstraZeneca Oncology Immuno Drug Major Product Offerings 7.4.4 AstraZeneca Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.4.5 AstraZeneca Key News 7.5 Sanofi S.A. 7.5.1 Sanofi S.A. Corporate Summary 7.5.2 Sanofi S.A. Business Overview 7.5.3 Sanofi S.A. Oncology Immuno Drug Major Product Offerings 7.5.4 Sanofi S.A. Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.5.5 Sanofi S.A. Key News 7.6 Dendreon Pharmaceuticals 7.6.1 Dendreon Pharmaceuticals Corporate Summary 7.6.2 Dendreon Pharmaceuticals Business Overview 7.6.3 Dendreon Pharmaceuticals Oncology Immuno Drug Major Product Offerings 7.6.4 Dendreon Pharmaceuticals Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.6.5 Dendreon Pharmaceuticals Key News 7.7 Novartis 7.7.1 Novartis Corporate Summary 7.7.2 Novartis Business Overview 7.7.3 Novartis Oncology Immuno Drug Major Product Offerings 7.7.4 Novartis Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.7.5 Novartis Key News 7.8 Gilead Sciences Inc. 7.8.1 Gilead Sciences Inc. Corporate Summary 7.8.2 Gilead Sciences Inc. Business Overview 7.8.3 Gilead Sciences Inc. Oncology Immuno Drug Major Product Offerings 7.8.4 Gilead Sciences Inc. Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.8.5 Gilead Sciences Inc. Key News 7.9 Merck KGaA 7.9.1 Merck KGaA Corporate Summary 7.9.2 Merck KGaA Business Overview 7.9.3 Merck KGaA Oncology Immuno Drug Major Product Offerings 7.9.4 Merck KGaA Oncology Immuno Drug Sales and Revenue in Global (2017-2022) 7.9.5 Merck KGaA Key News 8 Global Oncology Immuno Drug Production Capacity, Analysis 8.1 Global Oncology Immuno Drug Production Capacity, 2017-2028 8.2 Oncology Immuno Drug Production Capacity of Key Manufacturers in Global Market 8.3 Global Oncology Immuno Drug Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Oncology Immuno Drug Supply Chain Analysis 10.1 Oncology Immuno Drug Industry Value Chain 10.2 Oncology Immuno Drug Upstream Market 10.3 Oncology Immuno Drug Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Oncology Immuno Drug Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer
List of Tables Table 1. Key Players of Oncology Immuno Drug in Global Market Table 2. Top Oncology Immuno Drug Players in Global Market, Ranking by Revenue (2021) Table 3. Global Oncology Immuno Drug Revenue by Companies, (US$, Mn), 2017-2022 Table 4. Global Oncology Immuno Drug Revenue Share by Companies, 2017-2022 Table 5. Global Oncology Immuno Drug Sales by Companies, (K Units), 2017-2022 Table 6. Global Oncology Immuno Drug Sales Share by Companies, 2017-2022 Table 7. Key Manufacturers Oncology Immuno Drug Price (2017-2022) & (US$/Unit) Table 8. Global Manufacturers Oncology Immuno Drug Product Type Table 9. List of Global Tier 1 Oncology Immuno Drug Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Oncology Immuno Drug Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Oncology Immuno Drug Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Global Oncology Immuno Drug Revenue (US$, Mn), 2017-2022 Table 13. By Type - Global Oncology Immuno Drug Revenue (US$, Mn), 2023-2028 Table 14. By Type - Global Oncology Immuno Drug Sales (K Units), 2017-2022 Table 15. By Type - Global Oncology Immuno Drug Sales (K Units), 2023-2028 Table 16. By Application – Global Oncology Immuno Drug Revenue, (US$, Mn), 2021 & 2028 Table 17. By Application - Global Oncology Immuno Drug Revenue (US$, Mn), 2017-2022 Table 18. By Application - Global Oncology Immuno Drug Revenue (US$, Mn), 2023-2028 Table 19. By Application - Global Oncology Immuno Drug Sales (K Units), 2017-2022 Table 20. By Application - Global Oncology Immuno Drug Sales (K Units), 2023-2028 Table 21. By Region – Global Oncology Immuno Drug Revenue, (US$, Mn), 2021 VS 2028 Table 22. By Region - Global Oncology Immuno Drug Revenue (US$, Mn), 2017-2022 Table 23. By Region - Global Oncology Immuno Drug Revenue (US$, Mn), 2023-2028 Table 24. By Region - Global Oncology Immuno Drug Sales (K Units), 2017-2022 Table 25. By Region - Global Oncology Immuno Drug Sales (K Units), 2023-2028 Table 26. By Country - North America Oncology Immuno Drug Revenue, (US$, Mn), 2017-2022 Table 27. By Country - North America Oncology Immuno Drug Revenue, (US$, Mn), 2023-2028 Table 28. By Country - North America Oncology Immuno Drug Sales, (K Units), 2017-2022 Table 29. By Country - North America Oncology Immuno Drug Sales, (K Units), 2023-2028 Table 30. By Country - Europe Oncology Immuno Drug Revenue, (US$, Mn), 2017-2022 Table 31. By Country - Europe Oncology Immuno Drug Revenue, (US$, Mn), 2023-2028 Table 32. By Country - Europe Oncology Immuno Drug Sales, (K Units), 2017-2022 Table 33. By Country - Europe Oncology Immuno Drug Sales, (K Units), 2023-2028 Table 34. By Region - Asia Oncology Immuno Drug Revenue, (US$, Mn), 2017-2022 Table 35. By Region - Asia Oncology Immuno Drug Revenue, (US$, Mn), 2023-2028 Table 36. By Region - Asia Oncology Immuno Drug Sales, (K Units), 2017-2022 Table 37. By Region - Asia Oncology Immuno Drug Sales, (K Units), 2023-2028 Table 38. By Country - South America Oncology Immuno Drug Revenue, (US$, Mn), 2017-2022 Table 39. By Country - South America Oncology Immuno Drug Revenue, (US$, Mn), 2023-2028 Table 40. By Country - South America Oncology Immuno Drug Sales, (K Units), 2017-2022 Table 41. By Country - South America Oncology Immuno Drug Sales, (K Units), 2023-2028 Table 42. By Country - Middle East & Africa Oncology Immuno Drug Revenue, (US$, Mn), 2017-2022 Table 43. By Country - Middle East & Africa Oncology Immuno Drug Revenue, (US$, Mn), 2023-2028 Table 44. By Country - Middle East & Africa Oncology Immuno Drug Sales, (K Units), 2017-2022 Table 45. By Country - Middle East & Africa Oncology Immuno Drug Sales, (K Units), 2023-2028 Table 46. Bristol-Myers Squibb Corporate Summary Table 47. Bristol-Myers Squibb Oncology Immuno Drug Product Offerings Table 48. Bristol-Myers Squibb Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 49. Merck & Co Corporate Summary Table 50. Merck & Co Oncology Immuno Drug Product Offerings Table 51. Merck & Co Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 52. Roche AG Corporate Summary Table 53. Roche AG Oncology Immuno Drug Product Offerings Table 54. Roche AG Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 55. AstraZeneca Corporate Summary Table 56. AstraZeneca Oncology Immuno Drug Product Offerings Table 57. AstraZeneca Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 58. Sanofi S.A. Corporate Summary Table 59. Sanofi S.A. Oncology Immuno Drug Product Offerings Table 60. Sanofi S.A. Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 61. Dendreon Pharmaceuticals Corporate Summary Table 62. Dendreon Pharmaceuticals Oncology Immuno Drug Product Offerings Table 63. Dendreon Pharmaceuticals Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 64. Novartis Corporate Summary Table 65. Novartis Oncology Immuno Drug Product Offerings Table 66. Novartis Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 67. Gilead Sciences Inc. Corporate Summary Table 68. Gilead Sciences Inc. Oncology Immuno Drug Product Offerings Table 69. Gilead Sciences Inc. Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 70. Merck KGaA Corporate Summary Table 71. Merck KGaA Oncology Immuno Drug Product Offerings Table 72. Merck KGaA Oncology Immuno Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 73. Oncology Immuno Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units) Table 74. Global Oncology Immuno Drug Capacity Market Share of Key Manufacturers, 2020-2022 Table 75. Global Oncology Immuno Drug Production by Region, 2017-2022 (K Units) Table 76. Global Oncology Immuno Drug Production by Region, 2023-2028 (K Units) Table 77. Oncology Immuno Drug Market Opportunities & Trends in Global Market Table 78. Oncology Immuno Drug Market Drivers in Global Market Table 79. Oncology Immuno Drug Market Restraints in Global Market Table 80. Oncology Immuno Drug Raw Materials Table 81. Oncology Immuno Drug Raw Materials Suppliers in Global Market Table 82. Typical Oncology Immuno Drug Downstream Table 83. Oncology Immuno Drug Downstream Clients in Global Market Table 84. Oncology Immuno Drug Distributors and Sales Agents in Global Market List of Figures Figure 1. Oncology Immuno Drug Segment by Type Figure 2. Oncology Immuno Drug Segment by Application Figure 3. Global Oncology Immuno Drug Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Oncology Immuno Drug Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Oncology Immuno Drug Revenue, 2017-2028 (US$, Mn) Figure 7. Oncology Immuno Drug Sales in Global Market: 2017-2028 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Oncology Immuno Drug Revenue in 2021 Figure 9. By Type - Global Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 10. By Type - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 11. By Type - Global Oncology Immuno Drug Price (US$/Unit), 2017-2028 Figure 12. By Application - Global Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 13. By Application - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 14. By Application - Global Oncology Immuno Drug Price (US$/Unit), 2017-2028 Figure 15. By Region - Global Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 16. By Region - Global Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 17. By Country - North America Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 18. By Country - North America Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 19. US Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 20. Canada Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 21. Mexico Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 22. By Country - Europe Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 23. By Country - Europe Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 24. Germany Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 25. France Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 26. U.K. Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 27. Italy Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 28. Russia Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 29. Nordic Countries Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 30. Benelux Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 31. By Region - Asia Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 32. By Region - Asia Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 33. China Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 34. Japan Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 35. South Korea Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 36. Southeast Asia Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 37. India Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 38. By Country - South America Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 39. By Country - South America Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 40. Brazil Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 41. Argentina Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 42. By Country - Middle East & Africa Oncology Immuno Drug Revenue Market Share, 2017-2028 Figure 43. By Country - Middle East & Africa Oncology Immuno Drug Sales Market Share, 2017-2028 Figure 44. Turkey Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 45. Israel Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 46. Saudi Arabia Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 47. UAE Oncology Immuno Drug Revenue, (US$, Mn), 2017-2028 Figure 48. Global Oncology Immuno Drug Production Capacity (K Units), 2017-2028 Figure 49. The Percentage of Production Oncology Immuno Drug by Region, 2021 VS 2028 Figure 50. Oncology Immuno Drug Industry Value Chain Figure 51. Marketing Channels
72
This report studies the Breast Lesion Localization Methods market, including wire localization ... Read More
Performing lateral patient transfers is a common task in the daily tasks of healthcare workers. A ... Read More
Needleless IV Connectors are utilized to connect catheters to syringes or IV systems and Needlele ... Read More
Health care professionals use IV flush syringes to clear out patients’ catheters and intravenou ... Read More